Biographical Sketch
Bernard Silver, MD, is a Staff Member in the Department of Hematological Oncology and Blood Disorders at the Cleveland Clinic’s main campus. His specialty interests include Coagulation disorders (bleeding and thrombosis), including hemophilia, von Willebrand's disease, clotting factor deficiencies or inhibitors, thrombophilia (excess clotting), lupus anticoagulant or antiphospholipid syndrome, thrombocytopenia (ITP, TTP), and hemolytic anemia.
Dr. Silver is also an Associate Editor of the Cleveland Clinic Journal of Medicine, Course Director for Hematology at Cleveland Clinic Lerner College of Medicine and Program Director of bone marrow biopsies for Taussig Cancer Institute.
Dr. Silver earned his medical degree from the University of Michigan Medical School in Ann Arbor, Mich. He completed an internship and residency at Northwestern University Evanston Hospital in Evanston, IL. He also completed a fellowship at University of Michigan Health System in Ann Arbor.
He is board certified by the American Board of Internal Medicine with additional certifications in Hematology and Oncology.
He has been an invited lecturer and presenter on various aspects of coagulation, such as hemophilia, von Willebrand's disease and factor inhibitors as well as antiphospholipid syndrome and thrombophilia, among many others. Dr. Silver has also published a number of articles in peer-reviewed journals on topics related to anemia and adult thrombotic thrombocytopenic purpura.
Specialty Interests
clotting factor deficiencies or inhibitors, Coagulation disorders (bleeding and thrombosis), hemolytic anemia, Hemophilia, lupus anticoagulant or antiphospholipid syndrome, thrombocytopenia (ITP,TTP), thrombophilia (excess clotting), von willebrand's disease
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 7/31/2008,
Dr. Silver has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
